Delaware.gov Logo
Delaware.gov Logo Text

Menu

Currently Selected Location
Population: More Details

Selected location:

Key Data and Reports

Youth Use of Prescription Pain Meds without Prescription in Delaware

Data are current as of 2018

Most recent dashboard update: 5/31/2022

Percentage

2018

14%
of respondents
Loading...
Decreased 22% from 2011 to 2018

Investigate Maps

Delaware Youth Use of Rx Pain Meds without Prescription, 2011 to 2018

Delaware Youth Use of Rx Pain Meds without Prescription, 2011 to 2018

Of sample population


0%
Insufficient
data

Treatment Providers and Naloxone Distribution Centers

The treatment providers and naloxone distribution centers map is currently offline while we work to bring the provider list back up to date. In the meantime, please see the Help is Here – Treatment & Recovery website to learn where treatment centers are located.

Help is Here Delaware

Investigate Over Time

Youth Use of Prescription Pain Meds without Prescription in Delaware

Data are current as of 2018

Most recent dashboard update: 5/31/2022

Youth Use of Prescription Pain Meds without Prescription (Youth Self-Reported Use of Prescription Pain Meds without Prescription) in Delaware

Percentage of respondents

Data Sources
Delaware School Survey

Citation: University of Delaware, Center for Drug and Health Studies. Delaware School Survey. 2011-2018.

Additional Information

Youth Use of Prescription Pain Meds without Prescription in Delaware

Resources


Help is Here Delaware

Prevention, Addiction, Treatment, and Recovery resources for Delaware

Where to obtain naloxone

National Map of Naloxone Locations

Healthy Homes Prescription Drop Off Locations

All permanent prescription drop-off locations in Delaware

Privacy


In releasing this information, Delaware aims to provide information that can be helpful to local communities as they work to improve public health. However, the protection of the confidentiality of our citizens is of paramount importance. To that end, counts of less than 11 are not presented. An outside expert has reviewed the platform to ensure it complies with the HIPAA privacy rule (45 CFR 164.§514(b)).